CTLA4 and neoplasm: Mice treated with the combination of AHCC® and DICB had increased expression of the cytotoxic molecule granzyme B, the cell proliferation marker Ki-67, and the cell activation marker CTLA-4 by tumor infiltrating CD8+ T cells compared to mice treated with water and DICB (Figure 2A).